# Capecitabine in Treating Patients With Metastatic Breast Cancer

> **NCT00274768** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 26 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** capecitabine

## Key facts

- **NCT ID:** NCT00274768
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2009-12
- **Final completion:** 2012-11
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2020-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00274768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00274768, "Capecitabine in Treating Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00274768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*